Aiforia Data, Analytics & Interoperability: Features, Pricing & Alternatives
Deep learning AI and cloud platform for digital pathology image analysis
Aiforia is a Helsinki-based health technology company that develops deep learning AI and cloud software for digital pathology. Its platform spans CE-IVD marked clinical diagnostics, preclinical research, and no-code custom AI model development.
Our take
Aiforia is best suited for Pathology laboratories, preclinical research organizations, and veterinary diagnostic labs seeking AI-assisted image analysis and digital pathology workflows. Broad CE-IVD marked clinical AI portfolio spanning multiple cancer types.
Main limitation: no public pricing; all deals are demo-led and opaque. Scored 3.3/5 across the EHRAtlas scorecard.
Aiforia Overview
Aiforia is a Finnish digital pathology AI vendor founded in 2013 and headquartered in Helsinki. It builds cloud software that applies deep learning to whole-slide pathology images, serving clinical diagnostic labs, preclinical and academic research groups, and veterinary diagnostic labs across more than 50 countries.
The Aiforia Platform bundles image management, an interactive slide viewer, case-centric reporting, and a portfolio of quantitative AI models. Aiforia Create lets users without coding experience build, customize, and validate their own deep learning models, which is a notable differentiator versus vendors that only ship fixed algorithms.
Clinically, Aiforia offers CE-IVD marked suites for breast, lung, prostate, colon, and gastric cancer under IVDR. The company states its solutions are developed and maintained per ISO 27001, SOC 2 Type II, ISO 13485, and IVDR requirements with GDPR adherence. Aiforia is not an EHR or RCM product and holds no ONC certification.
Latest Aiforia News
Aiforia Evaluation
Scored against the same 7 dimensions used in the EHRAtlas Scorecard. 0 = not enough public information to score. These are analyst estimates, not endorsements — verify during a demo. Buyers should validate capabilities, pricing, implementation requirements, and fit during vendor evaluation.
Age, customer base, feature depth.
Operating since 2013 with a public listing on Nasdaq First North Growth Market Sweden, a CE-IVD clinical portfolio, and a stated base of 5,000+ users in 50+ countries. Feature depth spans clinical, research, and veterinary workflows, though it is smaller than Paige or PathAI in US clinical footprint.
Solo/small, mid, enterprise, or niche.
Serves mid-size and enterprise clinical pathology labs, pharma and CRO preclinical research groups, academic labs, and veterinary diagnostics. The research/CRO segment is a genuine niche where Aiforia has real traction, and clinical labs in EU/EEA are a growing base.
What sets it apart from alternatives.
Aiforia Create is a true no-code model-building environment, which few competitors match. Combined with transparent visual overlays on slides, a broad CE-IVD portfolio, and a single cloud platform spanning clinical, research, and veterinary use, the differentiation is meaningful though not unique versus Paige or PathAI.
Systems it connects to out of the box.
Aiforia states support for all major WSI scanners and file formats and compatibility with lab software such as LIS and PACS, but does not publish a named integration catalog. Buyers should validate specific LIS/scanner combinations during procurement.
HIPAA, SOC 2, ONC, FDA, other.
Strong EU-side posture: ISO 27001, SOC 2 Type II, ISO 13485, IVDR, and GDPR, plus CE-IVD marked clinical applications. No FDA clearance or 510(k) for US clinical use and no ONC certification, which limits US clinical adoption relative to Paige.
In-house vs outsourced, SLAs, channels.
Aiforia provides customer success and technical support as a commercial vendor, but published SLA terms, tiered support levels, and channel partner details are not readily available. Buyers should negotiate SLAs contractually.
How it charges and what the entry point is.
No public price list. Aiforia sells via demo-led enterprise engagements, typically subscription-based per seat, per scanner, or per case volume depending on configuration. Entry point is not transparent, which slows evaluation for smaller labs.
Aiforia Pricing
| Practice Size | Monthly (per provider) | Implementation | Notes |
|---|---|---|---|
| Enterprise | Contact vendor | Contact vendor | No public pricing; demo request required. Deals are typically annual subscriptions scoped to scanner count, seat count, or case volume. |
Pricing is indicative. Always request a formal quote and ask about module, interface, and annual maintenance fees.
Key Features
Clinical AI Suites
CE-IVD marked deep learning models for breast, lung, prostate, colon, and gastric cancer with case-centric diagnostic workflows.
Aiforia Create
Cloud, no-code environment for building, customizing, and validating deep learning image analysis models without programming.
Aiforia Studies
Study-centric module for AI-assisted image analysis in non-clinical research, aligned with Good Laboratory Practice expectations.
Transparent AI Results
Visual overlays mark findings directly on the digital slide so pathologists can confirm results at any magnification.
Image Management
Cloud platform supporting major whole-slide scanners and file formats with worklist, viewer, and reporting tools.
Veterinary Solutions
Case-centric workflow and AI applications for veterinary diagnostic labs, including collaboration features.
Fit
Specialties Served
Integrations & Compliance
Capabilities
Systems It Connects To
- billing
- hie
- lab-int
Compliance
| Item | Status | Note |
|---|---|---|
| ONC Certified Health IT | No | Not listed in the ONC CHPL active database. |
| HIPAA | Not published | Not explicitly stated; Aiforia emphasizes GDPR, ISO 27001, and SOC 2 Type II instead. US clinical customers should confirm BAA availability. |
| SOC 2 Type II | Yes | Stated by the company as part of its security and compliance posture. |
| ISO 27001 | Yes | Stated by the company for information security management. |
| ISO 13485 | Yes | Stated by the company for medical device quality management. |
| IVDR | Yes | Clinical applications are CE-IVD marked under IVDR for EU/EEA diagnostic use. |
| GDPR | Yes | Stated by the company for handling of personal data. |
| FDA clearance | Not published | No FDA clearance or 510(k) publicly announced for US clinical diagnostic use; US offerings are typically RUO or performance studies only. |
Aiforia Pros & Cons
Pros
- Broad CE-IVD marked clinical AI portfolio spanning multiple cancer types
- Aiforia Create enables no-code custom model development, rare among pathology AI vendors
- Transparent visual overlays support explainability and pathologist trust
- Strong EU regulatory and security posture (IVDR, ISO 13485, ISO 27001, SOC 2 Type II, GDPR)
- Single platform covers clinical, preclinical research, and veterinary workflows
Cons
- No public pricing; all deals are demo-led and opaque
- No FDA clearance or 510(k), limiting US clinical diagnostic adoption
- Support SLAs and channel model are not published
- Named LIS/PACS integrations are not cataloged publicly
- Smaller US commercial presence than Paige or PathAI
Paige
AI digital pathology vendor with FDA-cleared products and a strong US clinical footprint.
Compare Aiforia vs Paige →PathAI
AI pathology platform spanning clinical diagnostics, pharma trials, and research.
Compare Aiforia vs PathAI →Proscia
Digital pathology software platform with AI tools and enterprise lab deployments.
Compare Aiforia vs Proscia →Explore EHR Software Ecosystem: Integrations, Partners & Add-Ons Compare Aiforia with other Oncology and Pathology EHR vendors or browse the full EHR & Healthcare Technology Solutions Index.
Are you Aiforia? Claim your vendor profile, add product details, and reach practices researching EHRs. Claim Profile/Get Listed
Spotted an error? We publish this data as-is from CMS sources. If a practice or vendor listing is wrong, email support@ehratlas.com and we'll review it.
About This Data & Methodology
Source: This profile is assembled from the vendor's public website (features, capabilities, customer stories, media, and product updates) and EHRAtlas analyst evaluation. Compliance claims, pricing, and integration details should be verified directly with the vendor before making a purchase decision.
Methodology: Where available, we extract structured facts (customers, outcomes, integrations, security certifications) directly from the vendor's own published pages. Claims are linked to their source. Scores reflect analyst judgment based on available public evidence and are not endorsements.
Updates: Vendors are re-scanned periodically. Profile last reviewed on the date shown in the hero.
Corrections: If you spot an error or a change in the vendor's product, capabilities, or pricing, email us and we'll review it.
Spotted an error or need to submit a correction? Email support@ehratlas.com.